Summary
Inflammatory breast cancer (IBC) is a clinically distinct and aggressive form of locally advanced breast cancer with largely unknown genetic determinants. Overexpression of the RhoC GTPase and of HER2, and decreased ER-expression are involved in IBC. Multimodality treatment has increased survival but prognosis is still poor. Novel molecular targets for improved neoadjuvant treatment are necessary. Using cDNA microarrays, we performed genome-wide expression profiling of pre-treatment tumour samples of 16 patients with IBC and 18 patients with non-stage-matched non-IBC. Rigid clinical diagnostic criteria according to the TNM classification of␣the American Joint Committee on Cancer were adopted. Unsupervised hierarchical clustering accurately distinguished IBC and non-IBC samples. A set of 50 discriminator genes was identified in a learning group of tumour samples and was successful in diagnosing IBC in a validation group of samples (accuracy of 88%). Exclusion of ER-related or HER2-related genes did not alter this discriminatory accuracy, indicating that the expression of other genes in addition to ER and HER2 characterize the IBC phenotype. The molecular signature of IBC revealed the overexpression of a large number of NF-κB target genes, explaining at least part of the aggressive nature of IBC. Successful validation of some of the overexpressed genes by immunohistochemistry or real-time quantitative PCR demonstrated the robustness of the cDNA microarray experiments. The results of our study provide potential targets for the treatment of patients with IBC.
Similar content being viewed by others
References
BJ Lee NE Tannenbaum (1924) ArticleTitleInflammatory carcinoma of the breast: a report of twenty-eight cases from the breast clinic of Memorial Hospital Surg Gynecol Obstet 39 580–595
KL Golen ParticleVan S Davies ZF Wu Y Wang CD Bucana H Root S Chandrasekharappa M Strawderman SP Ethier SD Merajver (1999) ArticleTitleA novel putative low-affinity insulin-like growth factor binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype Clin Cancer Res 5 2511–2519 Occurrence Handle10499627
KL Golen ParticleVan ZF Wu XT Qiao LW Bao SD Merajver (2000) ArticleTitleRhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype Cancer Res 60 5832–5838 Occurrence Handle11059780
GG Eynden ParticleVan den I Auwera ParticleVan der S Laere ParticleVan CG Colpaert P Dam Particlevan S Merajver CG Kleer AL Harris EA Marck ParticleVan LY Dirix PB Vermeulen (2004) ArticleTitleValidation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer Breast Cancer Res Treat 85 13–22 Occurrence Handle10.1023/B:BREA.0000021028.33926.a8 Occurrence Handle15039594
KL Golen ParticleVan ZF Wu XT Qiao L Bao SD Merajver (2000) ArticleTitleRhoC GTPase overexpression modulates induction of angiogenic factors in breast cells Neoplasia 2 418–425 Occurrence Handle10.1038/sj.neo.7900115 Occurrence Handle11191108
KL Golen ParticleVan (2003) ArticleTitleInflammatory breast cancer: relationship between growth factor signalling and motility in aggressive cancers Breast Cancer Res 5 174–179 Occurrence Handle10.1186/bcr598 Occurrence Handle12793901
GC Kleer KL Golen Particlevan SD Merajver (2000) ArticleTitleMolecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical␣syndrome and molecular determinants Breast Cancer Res 2 423–429 Occurrence Handle10.1186/bcr89 Occurrence Handle11250736
M Cristofanilli AU Buzdar Hortobagyi (2003) ArticleTitleUpdate on the management of inflammatory breast cancer Oncologist 8 141–148 Occurrence Handle10.1634/theoncologist.8-2-141 Occurrence Handle12697939
M Wu ZF Wu C Kumar-Sinha A Chinnaiyan SD Merajver (2004) ArticleTitleRhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells Breast Cancer Res Treat 84 3–12 Occurrence Handle10.1023/B:BREA.0000018426.76893.21 Occurrence Handle14999149
F Bertucci P Finetti J Rougemont E Charafe-Jauffret V Nasser B Loriod J Camerlo R Tagett C Tarpin G Houvenaeghel C Nguyen D Maraninchi J Jacquemier R Houlgatte D Birnbaum P Veins (2004) ArticleTitleGene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy Cancer Res 64 8558–8565 Occurrence Handle10.1158/0008-5472.CAN-04-2696 Occurrence Handle15574762
CG Colpaert PB Vermeulen I Benoy A Soubry F Roy ParticleVan P Beest Particlevan G Goovaerts LY Dirix P Dam Particlevan SB Fox AL Harris EA Marck ParticleVan (2003) ArticleTitleInflammatory breast cancer shows angiogenesis with high endothelial cell proliferation rate and strong E-cadherin expression Br J Cancer 88 718–725 Occurrence Handle10.1038/sj.bjc.6600807 Occurrence Handle12618881
InstitutionalAuthorNameAmerican Joint Committee on Cancer (2002) AJCC Cancer Staging Manual EditionNumber6 Springer Verlag New York – Berlin – Heidelberg 221–240
LD Miller PM Long L Wong S Mukherjee LM McShane ET Liu (2002) ArticleTitleOptimal gene expression analysis by microarrays Cancer Cell 2 353–361 Occurrence Handle10.1016/S1535-6108(02)00181-2 Occurrence Handle12450790
S Draghici P Khatri P Bhavsar A Shah SA Krawetz MA Tainsky (2003) ArticleTitleOnto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate Nucleic Acids Res 31 3775–3781 Occurrence Handle10.1093/nar/gkg624 Occurrence Handle12824416
KJ Livak TD Schmittgen (2001) ArticleTitleAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 402–408 Occurrence Handle10.1006/meth.2001.1262 Occurrence Handle11846609
I Auwera ParticleVan der SJ Laere ParticleVan GC Eynden ParticleVan den I Benoy P Dam Particlevan CG Colpaert SB Fox H Turley AL Harris EA Marck ParticleVan PB Vermeulen LY Dirix (2004) ArticleTitleIncreased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification Clin Cancer Res 10 7965–7971 Occurrence Handle10.1158/1078-0432.CCR-04-0063 Occurrence Handle15585631
CM Perou T Sorlie MB Eisen M Rijn Particlevan de SS Jeffrey CA Rees JR Pollack DT Ross H Johnsen LA Akslen O Fluge A Pergamenschikov C Williams SX Zhu PE Lonning AL Borresen-Dale PO Brown D Botstein (2000) ArticleTitleMolecular portraits of human breast tumours Nature 406 747–752 Occurrence Handle10.1038/35021093 Occurrence Handle10963602
TO Nielsen FD Hsu K Jensen M Cheang G Karaca Z Hu T Hernandez-Boussard C Livasy D Cowan L Dressler LA Akslen J Ragaz AM Gown CB Gilks M Rijn Particlevan de CM Perou (2004) ArticleTitleImmunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 5367–5374 Occurrence Handle10.1158/1078-0432.CCR-04-0220 Occurrence Handle15328174
M Karin A Lin (2002) ArticleTitleNF-kappaB at the crossroads of life and death Nat Immunol 3 221–227 Occurrence Handle10.1038/ni0302-221 Occurrence Handle11875461
Y Cao M Karin (2003) ArticleTitleNF-kappaB in mammary gland development and breast cancer J Mammary Gland Biol Neoplasia 8 215–223 Occurrence Handle10.1023/A:1025905008934 Occurrence Handle14635796
PC Cogswell DC Guttridge WK Funkhouser AS Baldwin SuffixJr (2000) ArticleTitleSelective activation of NF-kappaB subunits in human breast cancer: potential roles for NF-kappaB2/p52 and for Bcl-3 Oncogene 19 1123–1131 Occurrence Handle10.1038/sj.onc.1203412 Occurrence Handle10713699
DK Biswas Q Shi S Baily I Strickland S Ghosh AB Pardee JD Iglehart (2004) ArticleTitleNF-kappaB activation in human breast cancer specimens and its role in cell proliferation and apoptosis Proc Natl Acad Sci USA 101 10137–10142 Occurrence Handle10.1073/pnas.0403621101 Occurrence Handle15220474
MA Huber N Azotei B Baumann S Grünert A Sommer H Pehamberger N Kraut H Beug T Wirth (2004) ArticleTitleNF-kappaB is essential for epithelial–mesenchymal transition and metastasis in a model of breast cancer progression J Clin Invest 114 569–581 Occurrence Handle10.1172/JCI200421358 Occurrence Handle15314694
K Podar R Shringarpure YT Tai M Simoncini M Sattler K Ishitsuka PG Richardson T Hideshima D Chauhan KC Anderson (2004) ArticleTitleCaveolin-1 is required for vascular endothelial growth factor-triggered multiple myeloma cell migration and is targeted by bortezomib Cancer Res 64 7500–7506 Occurrence Handle10.1158/0008-5472.CAN-04-0124 Occurrence Handle15492276
van Golen, et al.: in press
EV Bobrovnikova-Marjon PL Marjon O Barbash DL Vander Jagt SF Abcouwer (2004) ArticleTitleExpression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1 Cancer Res 64 4858–4869 Occurrence Handle10.1158/0008-5472.CAN-04-0682 Occurrence Handle15256456
Q Pan LW Bao SD Merajver (2003) ArticleTitleTetrathiomolybdate inhibits␣angiogenesis and metastasis through suppression of the NF-kappaB signaling cascade Mol Cancer Res 1 701–706 Occurrence Handle12939395
JB Sunwoo Z Chen G Dong N Yeh BC Crowl E Sausville J Adams P Elliott C Waes ParticleVan (2001) ArticleTitleNovel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappaB, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma Clin Cancer Res 7 1419–1428 Occurrence Handle11350913
Q Pan CG Kleer KL Golen Particlevan J Irani KM Bottema C Bias M Carvalho ParticleDe EA Mesri DM Robins RD Dick GJ Brewer SD Merajver (2002) ArticleTitleCopper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis Cancer Res 62 4854–4859 Occurrence Handle12208730
P Tsai S Shiah M Lin C Wu M Kuo (2003) ArticleTitleUp-regulation of vascular␣endothelial growth factor C in breast cancer cells by heregulin-beta1 J Biol Chem 278 5570–5759
MR Saban S Memet DG Jackson J Ash AA Roig A Israel R Saban (2004) ArticleTitleVisualization of lymphatic vessels through NF-kappaB activity Blood 104 3228–3230 Occurrence Handle10.1182/blood-2004-04-1428 Occurrence Handle15271802
SA Benitah PF Valeron JC Lacal (2003) ArticleTitleROCK and nuclear factor-kappaB-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences Mol Biol Cell 14 3041–3054 Occurrence Handle10.1091/mbc.E03-01-0016 Occurrence Handle12857884
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Van Laere, S., Van der Auwera, I., Van den Eynden, G.G. et al. Distinct Molecular Signature of Inflammatory Breast Cancer by cDNA Microarray Analysis. Breast Cancer Res Treat 93, 237–246 (2005). https://doi.org/10.1007/s10549-005-5157-z
Issue Date:
DOI: https://doi.org/10.1007/s10549-005-5157-z